Neuberger Berman Group Portfolio holdings
Neuberger Berman is an employee-owned investment manager that runs stock, bond, private equity and hedge fund portfolios for institutions, advisers and high net worth individuals. Art collector Roy Neuberger and banker Robert Berman co-founded the firm in 1939. Lehman Brothers bought it in 2003, and after Lehman collapsed in 2008 the firm's own managers won a bankruptcy auction for it, spinning it off in 2009 and returning it to full employee ownership by the end of 2014. Since going independent it has moved beyond its traditional focus on stocks into emerging markets debt, high-yield bonds and private equity, and in 2024 it led a private equity group that agreed to buy the school operator Nord Anglia Education. Art has been part of the firm's workplace culture since Roy Neuberger co-founded it, and it bought back many pieces of its collection at auction in 2010 after Lehman had absorbed them.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$463M |
| 2 |
Apple
AAPL
|
+$418M |
| 3 |
SpaceX
SPCX
|
+$361M |
| 4 |
NVIDIA
NVDA
|
+$291M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$428M |
| 2 |
Microsoft
MSFT
|
+$314M |
| 3 |
Boston Scientific
BSX
|
+$269M |
| 4 |
Teradyne
TER
|
+$249M |
| 5 |
T-Mobile US
TMUS
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.73% |
| 2 | Financials | 12.28% |
| 3 | Industrials | 12.11% |
| 4 | Healthcare | 8.91% |
| 5 | Consumer Discretionary | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2151
CG Oncology
CGON
$6.17B
| $211K | ﹤0.01% |
+2,970
| New | +$194K |
2026 Q2
0 quarters
|
|
2152
DELISTED
Select Medical
SEM
| $211K | ﹤0.01% |
12,762
-954
| -7% | -$15.7K |
2025 Q4
2 quarters
|
|
2153
DELISTED
CBIZ
CBZ
| $210K | ﹤0.01% |
+6,558
| New | +$204K |
2026 Q2
0 quarters
|
|
2154
Oruka Therapeutics
ORKA
$7.08B
| $210K | ﹤0.01% |
+2,210
| New | +$147K |
2026 Q2
0 quarters
|
|
2155
Insperity
NSP
$1.89B
| $210K | ﹤0.01% |
+5,081
| New | +$167K |
2026 Q2
0 quarters
|
|
2156
Leonardo DRS
DRS
$9.6B
| $209K | ﹤0.01% |
4,908
+7
| +0.1% | +$311 |
2026 Q1
1 quarter
|
|
2157
Saul Centers
BFS
$708M
| $209K | ﹤0.01% |
+5,596
| New | +$195K |
2026 Q2
0 quarters
|
|
2158
Iovance Biotherapeutics
IOVA
$3.56B
| $209K | ﹤0.01% |
50,280
+3,621
| +8% | +$13.8K |
2024 Q2
8 quarters
|
|
2159
Advance Auto Parts
AAP
$2.78B
| $209K | ﹤0.01% |
+3,352
| New | +$190K |
2026 Q2
0 quarters
|
|
2160
Harmony Biosciences
HRMY
$1.97B
| $209K | ﹤0.01% |
+5,727
| New | +$181K |
2026 Q2
0 quarters
|
|
2161
Centrus Energy
LEU
$2.2B
| $208K | ﹤0.01% |
+1,242
| New | +$232K |
2026 Q2
0 quarters
|
|
2162
DNOW Inc
DNOW
$2.52B
| $208K | ﹤0.01% |
16,035
+3,824
| +31% | +$49.6K |
2025 Q4
2 quarters
|
|
2163
Burford Capital
BUR
$709M
| $208K | ﹤0.01% |
50,711
+12,952
| +34% | +$59.2K |
2021 Q1
21 quarters
|
|
2164
Vita Coco
COCO
$3.78B
| $207K | ﹤0.01% |
+3,137
| New | +$212K |
2026 Q2
0 quarters
|
|
2165
Aurora
AUR
$8.87B
| $206K | ﹤0.01% |
30,171
-251
| -0.8% | -$1.54K |
2025 Q4
2 quarters
|
|
2166
HubSpot
HUBS
$10.6B
| $205K | ﹤0.01% |
1,122
-720
| -39% | -$151K |
2017 Q2
36 quarters
|
|
2167
Bank of N.T. Butterfield & Son
NTB
$2.22B
| $205K | ﹤0.01% |
+3,440
| New | +$195K |
2026 Q2
0 quarters
|
|
2168
Visteon
VC
$1.97B
| $204K | ﹤0.01% |
+2,060
| New | +$225K |
2026 Q2
0 quarters
|
|
2169
Walker & Dunlop
WD
$1.36B
| $204K | ﹤0.01% |
+3,726
| New | +$189K |
2026 Q2
0 quarters
|
|
2170
GRAIL Inc
GRAL
$5.32B
| $203K | ﹤0.01% |
+2,976
| New | +$175K |
2026 Q2
0 quarters
|
|
2171
National Bank Holdings
NBHC
$1.64B
| $203K | ﹤0.01% |
+4,570
| New | +$193K |
2026 Q2
0 quarters
|
|
2172
Invesco Variable Rate Preferred ETF
VRP
$2.96B
| $203K | ﹤0.01% |
8,335
-800
| -9% | -$19.5K |
2020 Q4
22 quarters
|
|
2173
Simply Good Foods
SMPL
$1.12B
| $203K | ﹤0.01% |
15,254
+4,049
| +36% | +$50K |
2020 Q1
25 quarters
|
|
2174
Relay Therapeutics
RLAY
$4.17B
| $202K | ﹤0.01% |
10,822
+774
| +8% | +$11.2K |
2026 Q1
1 quarter
|
|
2175
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.25B
| $202K | ﹤0.01% |
+2,945
| New | +$197K |
2026 Q2
0 quarters
|
|
Similar funds
Neuberger Berman Group's Q2 2026 Portfolio in Review
As of Q2 2026, Neuberger Berman Group held 2,421 positions worth $150B, up 14% from $131B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Neuberger Berman Group's Q2 2026 filing shows 259 new, 1,157 increased, 848 reduced and 81 closed positions. Its largest new stake was SpaceX: 2,127,228 shares worth $363M. The largest sale was Advanced Micro Devices, an estimated $428M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 25% a quarter earlier, followed by Financials and Industrials.
- Neuberger Berman Group's largest Q2 2026 buy was SpaceX: 2,127,228 shares worth $363M.
- Neuberger Berman Group added most to Amazon in Q2 2026, an estimated $463M increase.
- Neuberger Berman Group's biggest Q2 2026 reduction was Advanced Micro Devices, cutting an estimated $428M.
- Neuberger Berman Group fully exited Hologic in Q2 2026, selling an estimated $103M.
- Neuberger Berman Group's ten largest holdings make up 23% of its $150B portfolio in Q2 2026.
- Neuberger Berman Group opened 259 new positions and closed 81 in Q2 2026.
- Neuberger Berman Group's portfolio value rose 14% quarter-over-quarter to $150B.
Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.